Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2468074263;74264;74265 chr2:178572094;178572093;178572092chr2:179436821;179436820;179436819
N2AB2303969340;69341;69342 chr2:178572094;178572093;178572092chr2:179436821;179436820;179436819
N2A2211266559;66560;66561 chr2:178572094;178572093;178572092chr2:179436821;179436820;179436819
N2B1561547068;47069;47070 chr2:178572094;178572093;178572092chr2:179436821;179436820;179436819
Novex-11574047443;47444;47445 chr2:178572094;178572093;178572092chr2:179436821;179436820;179436819
Novex-21580747644;47645;47646 chr2:178572094;178572093;178572092chr2:179436821;179436820;179436819
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATT
  • RefSeq wild type template codon: TAA
  • Domain: Fn3-67
  • Domain position: 65
  • Structural Position: 98
  • Q(SASA): 0.4422
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/F rs1381899333 None 0.981 N 0.341 0.223 0.611199080189 gnomAD-3.1.2 1.32E-05 None None None None N None 0 0 0 0 0 None 0 0 2.94E-05 0 0
I/F rs1381899333 None 0.981 N 0.341 0.223 0.611199080189 gnomAD-4.0.0 3.0451E-06 None None None None N None 0 0 None 0 0 None 0 0 3.61493E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.2665 likely_benign 0.2865 benign -1.082 Destabilizing 0.762 D 0.355 neutral None None None None N
I/C 0.5784 likely_pathogenic 0.6059 pathogenic -0.856 Destabilizing 0.998 D 0.363 neutral None None None None N
I/D 0.6656 likely_pathogenic 0.6722 pathogenic -0.313 Destabilizing 0.94 D 0.389 neutral None None None None N
I/E 0.5031 ambiguous 0.5077 ambiguous -0.336 Destabilizing 0.921 D 0.391 neutral None None None None N
I/F 0.1769 likely_benign 0.1674 benign -0.747 Destabilizing 0.981 D 0.341 neutral N 0.462761592 None None N
I/G 0.5126 ambiguous 0.5279 ambiguous -1.338 Destabilizing 0.94 D 0.389 neutral None None None None N
I/H 0.3241 likely_benign 0.3392 benign -0.387 Destabilizing 0.996 D 0.403 neutral None None None None N
I/K 0.2635 likely_benign 0.2785 benign -0.623 Destabilizing 0.186 N 0.393 neutral None None None None N
I/L 0.091 likely_benign 0.0882 benign -0.488 Destabilizing 0.03 N 0.219 neutral N 0.439652659 None None N
I/M 0.1007 likely_benign 0.0983 benign -0.58 Destabilizing 0.938 D 0.365 neutral N 0.477037611 None None N
I/N 0.1686 likely_benign 0.1799 benign -0.519 Destabilizing 0.977 D 0.385 neutral N 0.417007873 None None N
I/P 0.7734 likely_pathogenic 0.7586 pathogenic -0.654 Destabilizing 0.994 D 0.409 neutral None None None None N
I/Q 0.2523 likely_benign 0.2748 benign -0.665 Destabilizing 0.986 D 0.421 neutral None None None None N
I/R 0.2182 likely_benign 0.2271 benign -0.063 Destabilizing 0.956 D 0.419 neutral None None None None N
I/S 0.175 likely_benign 0.1946 benign -1.098 Destabilizing 0.745 D 0.357 neutral N 0.374371816 None None N
I/T 0.1466 likely_benign 0.169 benign -0.995 Destabilizing 0.003 N 0.107 neutral N 0.36757913 None None N
I/V 0.0875 likely_benign 0.0903 benign -0.654 Destabilizing 0.039 N 0.225 neutral N 0.427608868 None None N
I/W 0.7778 likely_pathogenic 0.7651 pathogenic -0.757 Destabilizing 0.999 D 0.447 neutral None None None None N
I/Y 0.4603 ambiguous 0.4698 ambiguous -0.532 Destabilizing 0.887 D 0.367 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.